Late Stage Growth

Accolade - Partial Exit

Accolade was a late stage growth investment for RME and came at a time when RME wanted to increase its exposure to the healthcare sector.  The idea that Accolade is instrumental in lowering healthcare costs by helping employers and their employees better navigate the healthcare landscape was a win-win for all involved. Back in 2018, the Company was performing well but had a concentrated customer base which we believed kept it from being fully valued. The Company went public in July 2020 and has performed well - completing 2 key acquisitions and growing the top line at a very healthy clip. The Management team led by Rajeev Singh was very capable and had previously had a very successful exit as the President and Co-Founder of Concur.